Shweta Mital

Winnipeg, MB, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Budget impact analysis of capivasertib as a second-line therapy for advanced breast cancer in the United States.

Budget impact analysis of capivasertib as a second-line therapy for advanced breast cancer in the United States.

Journal: Expert review of pharmacoeconomics & outcomes research
Published: June 17, 2026

Everyone or Just Some? Cost-Effectiveness of General Population Versus Targeted Screening Strategies for Type 1 Diabetes in Canada.

Everyone or Just Some? Cost-Effectiveness of General Population Versus Targeted Screening Strategies for Type 1 Diabetes in Canada.

Journal: Diabetes care
Published: September 11, 2025

An Exploratory Cost-Effectiveness Analysis of Immune Therapy in Delaying the Initiation of Automated Insulin Delivery Systems in Type 1 Diabetes.

An Exploratory Cost-Effectiveness Analysis of Immune Therapy in Delaying the Initiation of Automated Insulin Delivery Systems in Type 1 Diabetes.

Journal: Diabetes technology & therapeutics
Published: May 12, 2025

Legalizing Youth-Friendly Cannabis Edibles and Extracts and Adolescent Cannabis Use.

Legalizing Youth-Friendly Cannabis Edibles and Extracts and Adolescent Cannabis Use.

Journal: JAMA network open
Published: April 18, 2025

Safer Opioid Supply, Subsequent Drug Decriminalization, and Opioid Overdoses.

Safer Opioid Supply, Subsequent Drug Decriminalization, and Opioid Overdoses.

Journal: JAMA health forum
Published: March 21, 2025

Effectiveness of educational interventions in United States schools to prevent opioid-related harms: A systematic review.

Effectiveness of educational interventions in United States schools to prevent opioid-related harms: A systematic review.

Journal: Addictive behaviors
Published: November 18, 2024

Cost-Effectiveness of Capivasertib as a Second-Line Therapy for Advanced Breast Cancer.

Cost-Effectiveness of Capivasertib as a Second-Line Therapy for Advanced Breast Cancer.

Journal: PharmacoEconomics
Published: November 06, 2024

Cost-effectiveness of nirsevimab and maternal RSVpreF for preventing respiratory syncytial virus disease in infants across Canada.

Cost-effectiveness of nirsevimab and maternal RSVpreF for preventing respiratory syncytial virus disease in infants across Canada.

Journal: BMC medicine
Published: September 06, 2024

Are E-Cigarettes Substitutes or Complements to Combustible Cigarettes Among Youths? Evidence From Canada.

Are E-Cigarettes Substitutes or Complements to Combustible Cigarettes Among Youths? Evidence From Canada.

Journal: Health economics
Published: June 27, 2024

Examining Safer Opioid Supply Policies-Reply.

Examining Safer Opioid Supply Policies-Reply.

Journal: JAMA internal medicine
Published: May 06, 2024

Recreational and Medical Cannabis Legalization and Opioid Prescriptions and Mortality.

Recreational and Medical Cannabis Legalization and Opioid Prescriptions and Mortality.

Journal: JAMA health forum
Published: January 19, 2024

British Columbia's Safer Opioid Supply Policy and Opioid Outcomes.

British Columbia's Safer Opioid Supply Policy and Opioid Outcomes.

Journal: JAMA internal medicine
Published: January 16, 2024
Showing 1-12 of 34

Last Updated: 09/26/2026